Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AtonRa Partners decreased its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,530 shares of the medical research company’s stock after selling 1,622 shares during the […]
AtonRa Partners reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 12.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,530 shares of the medical research company’s stock after selling 1,622 shares during the quarter. […]
Mayo Clinic increased its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 40.9% in the 1st quarter, Holdings Channel reports. The firm owned 5,151 shares of the medical research company’s stock after purchasing an additional 1,496 shares during the period. Exact Sciences accounts for approximately 0.3% of Mayo Clinic’s holdings, making the stock […]
Van ECK Associates Corp trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 15.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 167,782 shares of the medical research company’s stock after selling 30,116 shares during the quarter. Van ECK […]
TCI Wealth Advisors Inc. boosted its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 15,466.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 467 shares of the medical research company’s stock after acquiring an additional […]